PPAR-γ has been reported to control ATM alternative activation and improve insulin resistance [40], but its expression did not change after Etv5 silencing, indicating that there are other pathways regulated by ETV5 (Fig. 4A). The gene discussed is ATM; the disease is Insulin resistance.